Page last updated: 2024-10-28

haloperidol and Pain, Chronic

haloperidol has been researched along with Pain, Chronic in 1 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Research Excerpts

ExcerptRelevanceReference
"Patients with neuropathic pain are highly motivated for pain relief, and as motivational factors such as expectations of reward, as well as pain processing in itself, are related to the dopaminergic system, it can be speculated that dopamine release contributes to placebo effects in neuropathic pain."1.48Dopaminergic tone does not influence pain levels during placebo interventions in patients with chronic neuropathic pain. ( Baastrup, C; Benedetti, F; Grosen, K; Hall, KT; Jensen, TS; Kaptchuk, TJ; Moslemi, K; Petersen, GL; Price, DD; Skyt, I; Svensson, P; Vase, L, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Skyt, I1
Moslemi, K1
Baastrup, C1
Grosen, K1
Benedetti, F1
Petersen, GL1
Price, DD1
Hall, KT1
Kaptchuk, TJ1
Svensson, P1
Jensen, TS1
Vase, L1

Other Studies

1 other study available for haloperidol and Pain, Chronic

ArticleYear
Dopaminergic tone does not influence pain levels during placebo interventions in patients with chronic neuropathic pain.
    Pain, 2018, Volume: 159, Issue:2

    Topics: Adult; Aged; Anesthetics, Local; Carbidopa; Chronic Pain; Dopamine; Dopamine Agents; Drug Combinatio

2018